Osaic Holdings’s Dianthus Therapeutics DNTH Stock Holding History

Osaic Holdings’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.5K	Buy	232 +211	+1,005%	+$12.2K	﹤0.01%	5878
2025 Q4	$864	Hold	21	–	–	﹤0.01%	7312
2025 Q3	$717	Buy	21 +14	+200%	+$358	﹤0.01%	7458
2025 Q2	$130	Hold	7	–	–	﹤0.01%	7541
2025 Q1	$126	Hold	7	–	–	﹤0.01%	7212
2024 Q4	$152	Sell	7 -3,105	-100%	-$79.8K	﹤0.01%	7201
2024 Q3	$85.2K	Buy	+3,112	New	+$86.7K	﹤0.01%	4345
2022 Q2	–	Sell	-8	Closed	–	–	7400
2022 Q1	$0	Hold	8	–	–	﹤0.01%	7297
2021 Q4	$1K	Hold	8	–	–	﹤0.01%	7160
2021 Q3	$1K	Buy	+8	New	+$932	﹤0.01%	6999
2021 Q1	–	Sell	-63	Closed	-$8K	–	6827
2020 Q4	$8K	Hold	63	–	–	﹤0.01%	5602
2020 Q3	$7K	Buy	+63	New	+$7.46K	﹤0.01%	5434

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings's DNTH Position: Q1 2026 in Review

Osaic Holdings increased its Dianthus Therapeutics (DNTH) stake by 1,005% in Q1 2026, buying an estimated $12.2K and bringing the position to 232 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5878.

Osaic Holdings first reported a position in DNTH in Q3 2020 and has held it in 12 quarters since. The position peaked at $85.2K in Q3 2024. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

Osaic Holdings held 232 shares of Dianthus Therapeutics worth $19.5K as of Q1 2026.
Osaic Holdings bought 211 Dianthus Therapeutics shares in Q1 2026, an estimated $12.2K.
Dianthus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5878 holding.
Osaic Holdings first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 12 quarters since.
Osaic Holdings's Dianthus Therapeutics position peaked at $85.2K in Q3 2024.
241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.